eMedicine Specialties > Dermatology > Diseases of the Oral Mucosa

Hairy Tongue: Treatment & Medication

Author: Denis Lynch, DDS, PhD, Associate Dean for Academic Affairs, School of Dentistry, Office of the Dean, Marquette University
Contributor Information and Disclosures

Updated: Jun 25, 2009

Treatment

Medical Care

The treatment of hairy tongue is variable. In many cases, simply brushing the tongue with a toothbrush or using a commercially available tongue scraper is sufficient to remove elongated filiform papillae and retard the growth of additional ones.5

This male geriatric patient had smoked a pipe for...

This male geriatric patient had smoked a pipe for many years. He was unaware of the presence of his hairy tongue until it was brought to his attention during a routine dental examination.

This male geriatric patient had smoked a pipe for...

This male geriatric patient had smoked a pipe for many years. He was unaware of the presence of his hairy tongue until it was brought to his attention during a routine dental examination.



The same patient as in Image 5 one month followin...

The same patient as in Image 5 one month following his initial examination. While he has not decreased his pipe smoking, he has gently brushed the dorsal surface of his tongue when he brushes his teeth during the intervening 4 weeks. The hairy tongue has completely resolved.

The same patient as in Image 5 one month followin...

The same patient as in Image 5 one month following his initial examination. While he has not decreased his pipe smoking, he has gently brushed the dorsal surface of his tongue when he brushes his teeth during the intervening 4 weeks. The hairy tongue has completely resolved.

Surgical Care

Surgical removal of the papillae by using electrodesiccation, carbon dioxide laser, or even scissors is the treatment of last resort when less complicated therapies prove ineffective.

Consultations

Consultation with or referral to a general dentist may be indicated if the etiology of a patient's hairy tongue appears to be primarily one of poor oral hygiene.

Diet

Patients who are on a continuous soft diet occasionally develop hairy tongue because the consistency of the diet does nothing to mechanically debride the dorsal surface of the tongue during eating and swallowing. If adding more roughage to the patient's diet is not feasible, encourage the patient to cleanse the dorsal surface of the tongue daily by brushing or scraping.

Medication

In most cases, the treatment of hairy tongue does not require pharmacologic intervention. If Candida albicans is present, topical antifungal medications can be used when the condition is symptomatic (eg, glossopyrosis). Topical application of retinoids has been used with some success. Keratolytic agents are effective but may be irritating. Although reportedly successful, the agents listed above (with the exception of treatment of oral candidiasis) are used off label and their application should be limited to selected cases with close monitoring.

Antifungal agents

These agents are used to treat oral candidiasis in association with hairy tongue.


Clotrimazole (Mycelex)

Broad-spectrum antifungal agent that inhibits yeast growth by altering cell membrane permeability, causing death of fungal cells. Reevaluate diagnosis if no clinical improvement after 2 wk. Effective in the treatment of oral candidiasis; however, it has some drawbacks. Has high sugar content and peppermint flavor to mask the bitter taste of clotrimazole. High sugar content makes it relatively contraindicated in persons with diabetes. Dosing regimen occasionally results in poor patient compliance; nevertheless, it is an effective medication to treat oral candidiasis and is especially efficacious in treating candidal infections on the dorsal surface of the tongue.

Adult

10 mg troche dissolved in mouth 5 times/d for 2 wk; do not eat or drink for 30 min after treatment

Pediatric

Not established

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Not for treatment of systemic fungal infections; avoid contact with the eyes; discontinue use and institute appropriate therapy if irritation or sensitivity develops; caution in persons with diabetes because of high sugar content of troche; dental carries may occur in individuals who are prone; patients with xerostomia may not be able to dissolve troches


Nystatin (Mycostatin)

Fungicidal and fungistatic antibiotic obtained from Streptomyces noursei. Effective against various yeasts and yeastlike fungi. Changes permeability of fungal cell membrane after binding to cell membrane sterols, causing cellular contents to leak. Treatment should continue until 48 h after disappearance of symptoms. Drug is not significantly absorbed from GI tract.
Effective to treat oral candidiasis; however, it has some drawbacks. Has high sugar content and licorice flavor to mask the bitter taste of nystatin. High sugar content makes it relatively contraindicated in persons with diabetes. Some patients have an aversion to licorice flavoring. Dosing regimen occasionally results in poor patient compliance; nevertheless, it is an effective medication to treat oral candidiasis and is especially efficacious in treating candidal infections on the dorsal surface of the tongue.

Adult

200,000-400,000 U pastilles dissolved in mouth q4h for 2 wk; do not eat or drink for 30 min after treatment

Pediatric

Not established

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Do not use to treat systemic mycoses; caution in persons with diabetes because of high sugar content of pastille; dental carries may occur in individuals who are prone; patients with xerostomia may not be able to dissolve troches


Ketoconazole (Nizoral)

Fungistatic activity. Imidazole broad-spectrum antifungal agent. Inhibits synthesis of ergosterol, causing cellular components to leak and resulting in fungal cell death. Effective in treating oral candidiasis, especially when patients do not comply with multidosing topical therapies or are unable to tolerate sugar-containing troches and pastilles. Take with food.

Adult

200 mg PO qd for 2 wk

Pediatric

Not established

Isoniazid may decrease bioavailability; coadministration decreases effects of either rifampin or ketoconazole; may increase effect of anticoagulants; may increase toxicity of corticosteroids and cyclosporine (cyclosporine dosage can be adjusted); may decrease theophylline levels

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Hepatotoxicity may occur; may reversibly decrease corticosteroid serum levels (adverse effects avoided with dose of 200-400 mg/d); administer antacid, anticholinergics, or H2-blockers at least 2 h after ketoconazole


Fluconazole (Diflucan)

Fungistatic activity. Synthetic oral antifungal (broad-spectrum bistriazole) that selectively inhibits fungal cytochrome P-450 and sterol C-14 alpha-demethylation, which prevents conversion of lanosterol to ergosterol, thereby disrupting cellular membranes. Effective in treating oral candidiasis, especially when patients do not comply with multidosing topical therapies or are unable to tolerate sugar-containing troches and pastilles. Normally prescribed in situations where other topical or systemic medications have not been successful. Especially useful in treating oral candidiasis in patients who are immunosuppressed.

Adult

150 mg PO once or 400 mg qd, depending on severity of infection

Pediatric

Not established

Levels may increase with hydrochlorothiazide; levels may decrease with chronic coadministration of rifampin; coadministration may decrease phenytoin clearance; may increase concentrations of theophylline, tolbutamide, glyburide, and glipizide; effects of anticoagulants may increase with coadministration; increases in cyclosporine concentrations may occur when administered concurrently

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Adjust dose for renal insufficiency; monitor closely if rash develops and discontinue drug if lesions progress; may cause clinical hepatitis, cholestasis, and fulminant hepatic failure (including death) with underlying medical conditions (eg, AIDS, malignancy) or while taking multiple concomitant medications; not recommended in breastfeeding

More on Hairy Tongue

Overview: Hairy Tongue
Differential Diagnoses & Workup: Hairy Tongue
Treatment & Medication: Hairy Tongue
Follow-up: Hairy Tongue
Multimedia: Hairy Tongue
References
Further Reading

References

  1. Garg A, Wadhera R, Gulati SP, Goyal R. Hairy tongue. J Assoc Physicians India. Oct 2008;56:817-8. [Medline].

  2. Vañó-Galván S, Jaén P. Black hairy tongue. Cleve Clin J Med. Dec 2008;75(12):847-8. [Medline].

  3. Lawoyin D, Brown RS. Drug-induced black hairy tongue: diagnosis and management challenges. Dent Today. Jan 2008;27(1):60, 62-3; quiz 93, 58. [Medline].

  4. Pigatto PD, Spadari F, Meroni L, Guzzi G. Black hairy tongue associated with long-term oral erythromycin use. J Eur Acad Dermatol Venereol. Nov 2008;22(10):1269-70. [Medline].

  5. Kostka E, Wittekindt C, Guntinas-Lichius O. [Tongue coating, mouth odor, gustatory sense disorder - earlier and new treatment options by means of tongue scraper]. Laryngorhinootologie. Aug 2008;87(8):546-50. [Medline].

  6. [Guideline] New York State Department of Health. Oral health management of children and adolescents with HIV infections. New York State Department of Health. Jun 2004.

  7. [Guideline] Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Infectious Diseases Society of America. Mar 2009.

  8. [Guideline] Singapore Ministry of Health. Nursing management of oral hygiene. Singapore Ministry of Health. Dec 2004.

  9. Bouquot JE. Common oral lesions found during a mass screening examination. J Am Dent Assoc. Jan 1986;112(1):50-7. [Medline].

  10. Christen AG, Swanson BZ Jr. Oral hygiene: a history of tongue scraping and brushing. J Am Dent Assoc. Feb 1978;96(2):215-9. [Medline].

  11. Darwazeh AM, Pillai K. Prevalence of tongue lesions in 1013 Jordanian dental outpatients. Community Dent Oral Epidemiol. Oct 1993;21(5):323-4. [Medline].

  12. Donta AN, Lampadakis J, Pilalitos P, Spyropoulos ND. [Findings from the clinical examination of the oral cavity of one hundreddrug addicts]. Hell Stomatol Chron. Apr-Jun 1989;33(2):101-5. [Medline].

  13. Farman AG. Hairy tongue (lingua villosa). J Oral Med. Jul-Sep 1977;32(3):85-91. [Medline].

  14. Hasler JF, Standish SM. Podophyllin treatment of hairy tongue: a warning. J Am Dent Assoc. Mar 1969;78(3):563-7. [Medline].

  15. Heymann WR. Psychotropic agent-induced black hairy tongue. Cutis. Jul 2000;66(1):25-6. [Medline].

  16. Jarvinen J, Kullaa-Mikkonen A, Kotilainen R. Some local and systemic factors related to tongue inflammation. Proc Finn Dent Soc. 1989;85(3):199-209. [Medline].

  17. Kaplan I, Moskona D. A clinical survey of oral soft tissue lesions in institutionalized geriatric patients in Israel. Gerodontology. Summer 1990;9(2):59-62. [Medline].

  18. Kullaa-Mikkonen A, Mikkonen M, Kotilainen R. Prevalence of different morphologic forms of the human tongue in young Finns. Oral Surg Oral Med Oral Pathol. Feb 1982;53(2):152-6. [Medline].

  19. Langtry JA, Carr MM, Steele MC, Ive FA. Topical tretinoin: a new treatment for black hairy tongue (lingua villosa nigra). Clin Exp Dermatol. May 1992;17(3):163-4. [Medline].

  20. Levine N. Dark discoloration of the tongue. Geriatrics. Jun 1996;51(6):20. [Medline].

  21. Manabe M, Lim HW, Winzer M, Loomis CA. Architectural organization of filiform papillae in normal and black hairy tongue epithelium: dissection of differentiation pathways in a complex human epithelium according to their patterns of keratin expression. Arch Dermatol. Feb 1999;135(2):177-81. [Medline].

  22. McGregor JM, Hay RJ. Oral retinoids to treat black hairy tongue. Clin Exp Dermatol. May 1993;18(3):291. [Medline].

  23. Nally F. Diseases of the tongue. Practitioner. Jan 1991;235(1498):65-71. [Medline].

  24. Neville BW, Damm DD, Allen CM. Oral and Maxillofacial Pathology. 2nd ed. Philadelphia, Pa: WB Saunders; 2002.

  25. Newman CC, Wagner RF. Images in clinical medicine. Black hairy tongue. N Engl J Med. Sep 25 1997;337(13):897. [Medline].

  26. Pegum JS. Urea in the treatment of black hairy tongue. Br J Dermatol. Jun 1971;84(6):602. [Medline].

  27. Powell FC. Glossodynia and other disorders of the tongue. Dermatol Clin. Oct 1987;5(4):687-93. [Medline].

  28. Redman RS. Prevalence of geographic tongue, fissured tongue, median rhomboid glossitis, and hairy tongue among 3,611 Minnesota schoolchildren. Oral Surg Oral Med Oral Pathol. Sep 1970;30(3):390-5. [Medline].

  29. Regezi JA, Sciubba JJ, Jordan RCK. Oral Pathology - Clinical Pathologic Correlations. 5th ed. Philadelphia, Pa: WB Saunders; 2003.

  30. Salonen L, Axell T, Hellden L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med. Apr 1990;19(4):170-6. [Medline].

  31. Sapp JP, Eversole LR, Wysocki GP. Contemporary Oral and Maxillofacial Pathology. 2nd ed. St. Louis, Mo: Mosby-Year Book; 2004.

  32. Sarti GM, Haddy RI, Schaffer D, Kihm J. Black hairy tongue. Am Fam Physician. Jun 1990;41(6):1751-5. [Medline].

  33. Winzer M, Gilliar U. [Hairy tongue and hairy oral leukoplakia--a differential histopathologic diagnosis]. Z Hautkr. Jun 15 1988;63(6):517-20. [Medline].

  34. Winzer M, Gilliar U, Ackerman AB. Hairy lesions of the oral cavity. Clinical and histopathologic differentiation of hairy leukoplakia from hairy tongue. Am J Dermatopathol. Apr 1988;10(2):155-9. [Medline].

Further Reading

Clinical guidelines

Oral health management of children and adolescents with HIV infections. 6
New York State Department of Health - State/Local Government Agency [U.S.].  2003 (revised 2004 Jun).  9 pages.  NGC:003891

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. 7
Infectious Diseases Society of America - Medical Specialty Society.  2004 Jan 15 (revised 2009 Mar 1).  33 pages.  NGC:007081

Nursing management of oral hygiene. 8
Singapore Ministry of Health - National Government Agency [Non-U.S.].  2004 Dec.  33 pages.  NGC:004285


Clinical Trials


Neurogenic Mechanisms in Burning Mouth Syndrome

Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula


Related eMedicine topics


Hairy Leukoplakia

Chemotherapy-Induced Oral Mucositis

Oral Examination

Oral Manifestations of Systemic Diseases

Oral Frictional Hyperkeratosis

Keywords

lingua nigra, lingua villosa, lingua villosa nigra, black hairy tongue, defective desquamation of the filiform papillae, poor oral hygiene, therapeutic radiation, glossopyrosis, burning tongue, Candida albicans, halitosis, hypertrophy of filiform papillae, tobacco use, coffee drinking, tea drinking

Contributor Information and Disclosures

Author

Denis Lynch, DDS, PhD, Associate Dean for Academic Affairs, School of Dentistry, Office of the Dean, Marquette University
Denis Lynch, DDS, PhD is a member of the following medical societies: American Academy of Oral and Maxillofacial Pathology, American Dental Association, International Association for Dental Research, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Bernice R Krafchik, MBChB, FRCPC, Professor Emeritus, Department of Pediatrics, Section of Dermatology, University of Toronto
Bernice R Krafchik, MBChB, FRCPC is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, Canadian Medical Association, College of Physicians and Surgeons of Ontario, Royal College of Physicians and Surgeons of Canada, and Society for Pediatric Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati
Drore Eisen, MD, DDS is a member of the following medical societies: American Academy of Dermatology, American Academy of Oral Medicine, and American Dental Association
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.